Case study

Evaluating healthcare policies and possible funding pathways for CAR-T therapies in KSA

Client Situation

Our client is a leading provider of targeted therapies for treatment of rare diseases. They wanted to understand the evolving healthcare policies, potential access and funding opportunities in the private and public sector for DLBCL CAR-T therapies in KSA.

flag_image

Project Scope

To understand the healthcare policies and potential access, reimbursement, funding opportunities for DLBCL CAR-T therapies in KSA

Focus Markets

flag_image

Solutions

  • Conducted extensive primary research to get detailed insights on:
    ○Pricing and reimbursement process for high cost therapies in public and private sector
    ○National and hospital level and alternative funding pathways feasible for DLBCL CAR-T therapies
    ○Changes in healthcare policies in future impacting public funding for CAR-T in future
flag_image

Results

  • Enabled our client to understand local funding and access pathways for high cost therapies
  • Recommended approaches from payer viewpoint to secure funding for high cost therapies in both the private and public sectors